endogene.bio has been selected as one of the Hello Tomorrow Deep Tech Pioneers, recognizing the scientific depth and innovation behind our approach to advancing precision medicine in uterine health.
This recognition highlights the strength of our science as we build the first comprehensive molecular atlas of uterine diseases, laying the foundation for non-invasive diagnostics and personalized therapeutics in women's health.
We're proud to join a global community of deep tech innovators shaping the future of science-driven impact.
About endogene.bio
endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.
